Medical Equipment

Global Skin Biopsy Market Projected to Expand at 8.1% CAGR by 2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Skin Biopsy Market Size Likely To Evolve From 2025 Through 2034?

The skin biopsy market has experienced strong growth in recent years. It is anticipated to expand from $1.72 billion in 2024 to $1.86 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.4%. This historical growth can be attributed to the increasing prevalence of skin cancer and chronic skin disorders, a heightened awareness of early disease detection, the adoption of punch biopsy as a standard diagnostic tool, the expansion of hospital and clinic infrastructure, and supportive government initiatives for cancer screening programs.

The skin biopsy market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $2.54 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.1%. The expansion during this projection period is primarily driven by an escalating need for less invasive diagnostic methods, the incorporation of artificial intelligence into biopsy evaluations, an expanding older demographic susceptible to skin conditions, investments in healthcare sectors within developing nations, and the proliferation of teledermatology and virtual consultation offerings. Key developments expected within this forecast timeframe encompass a move towards digital pathology systems, the embrace of less invasive options such as liquid biopsy, customized treatment strategies based on biopsy outcomes, partnerships between medical device manufacturers and healthcare organizations, and the creation of easily portable and user-friendly biopsy instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

What Are The Main Drivers Boosting The Skin Biopsy Industry’s Expansion?

The increasing occurrence of skin conditions is anticipated to drive the expansion of the skin biopsy market in the future. Skin disorders encompass various conditions impacting the skin’s structure, function, or look, frequently leading to symptoms like inflammation, irritation, or unusual growths. These include acne, eczema, psoriasis, dermatitis, vitiligo, fungal infections, warts, and skin cancer. The frequency of skin disorders is growing, attributed to increased environmental pollution, which can harm the skin barrier and provoke inflammatory or allergic responses. Skin biopsy assists in diagnosing skin disorders by supplying precise tissue samples for microscopic analysis, facilitating early detection of conditions like infections, inflammatory diseases, and cancers, thereby enhancing treatment results and patient well-being. For example, in 2023, Cancer Australia, an Australia-based government agency, reported around 8,257 new diagnoses of melanoma of the skin, representing 2.6% of all cancer-related deaths. Consequently, the growing incidence of skin disorders is boosting the expansion of the skin biopsy market. Increased spending on healthcare is projected to drive the expansion of the skin biopsy market in the coming years. Healthcare expenditure denotes the overall financial outlay on medical services, treatments, facilities, research, and public health programs aimed at sustaining or enhancing health results. The growing need for healthcare spending stems from the increasing occurrence of chronic illnesses, which necessitate prolonged and expensive treatments. Increased healthcare spending promotes the uptake of skin biopsy procedures by making advanced diagnostic technologies more accessible and broadening dermatology services. This facilitates early and precise diagnosis of skin disorders, contributing to improved patient outcomes and greater healthcare efficiency. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure experienced a 5.6% rise in nominal terms in 2023, marking a 0.9% growth compared to 2022. Thus, the escalation in healthcare spending is propelling the growth of the skin biopsy market.

What Are The Leading Segments Analyzed In The Skin Biopsy Market?

The skin biopsy market covered in this report is segmented as

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy, Needle Biopsy

2) By Procedure Type: Surgical Biopsy, Imageguided Biopsy, Dermatoscopic Biopsy, Endoscopic Biopsy

3) By Application: Dermatology, Oncology, Pathology, Clinical Research, Cosmetic Procedures

4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Laboratories, Research Institutions, Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision, Saucerization

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (=) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

5) By Needle Biopsy: Fine-Needle Aspiration Biopsy (FNAB), Core Needle Biopsy, Vacuum-Assisted Needle Biopsy

Which Key Market Players Are Investing In Expansion And Innovation Of Skin Biopsy Market?

Major companies operating in the skin biopsy market are Olympus Corporation, Sysmex Corporation, Bio-Rad Laboratories, Exact Sciences Corporation, Cardinal Health Inc., Merit Medical Systems Inc., Abbott Laboratories, Danaher Corporation, Philips Healthcare, Becton, Dickinson and Company (BD), Hologic Inc., Cook Medical, Leica Biosystems Nussloch GmbH, AccuTec Inc., MedicalExpo brands, Delasco, Paramount Surgimed Ltd., Neoteryx, Innovia Medical, and World Precision Instruments.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

How Is Skin Biopsy Market Demand Varying Across Different Regions?

North America was the largest region in the skin biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in skin biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Skin Biopsy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28330&type=smp

Browse Through More Reports Similar to the Global Skin Biopsy Market 2025, By The Business Research Company

Skin Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report

Liquid Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795